Can I Take Mounjaro and Methotrexate Together? (October 2026)

01 · The core answer

Can you take Mounjaro and methotrexate together?

Sometimes, yes, but the decision belongs to the clinicians who know you. Mounjaro (tirzepatide) is a once-weekly injectable prescription medicine licensed in the UK for weight management in adults and for type 2 diabetes¹. Methotrexate is prescribed and monitored by a specialist or your GP under a shared plan. Neither prescriber can judge the combination well unless they know about the other medicine.

The most useful starting point is the Mounjaro patient information leaflet and the product information on the electronic medicines compendium¹³. Read the sections on other medicines, then take them to the clinician who looks after your methotrexate.

02 · Your decision

The decisions you are actually facing

Most people reading this are in one of a few positions.

In every row the common thread is communication. Mounjaro is supplied only after an online consultation reviewed by a GPhC-registered prescriber¹, and that prescriber can only weigh up the combination if methotrexate is on the list you give them.

03 · What next

What to do next

If you have talked to your specialist and want to explore treatment, you can read about the Mounjaro pen, its prices and the consultation. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

If you are still weighing up weight-management options generally, our weight loss clinic pages explain the wider picture. There is no pressure either way. For many people with a long-term condition, the right order is specialist conversation first, then treatment.

Related guide: Mounjaro with Methotrexate Weight Loss UK.

04 · How Mounjaro works

How Mounjaro works and why it matters for other medicines

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg¹. Understanding what it does in the body is the best way to understand why prescribers ask about your other medicines.

Tirzepatide activates two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin¹. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

The detail that matters for any combination question is the slower stomach emptying. Medicines taken by mouth pass through the stomach on their way to being absorbed. When the stomach empties more slowly, a prescriber will want to think about whether any tablets you take could be affected.

The same principle is why the product information and patient leaflet¹³ tell you to inform your prescriber about everything you take. The leaflet is written for the whole population of users, so it cannot tailor advice to your condition, your dose or your blood results. Your clinicians can.

It also helps to be clear about what Mounjaro is not. It is not a treatment for arthritis, and it does not replace the medicines your specialist has chosen to control your condition. It is licensed for weight management in adults and for type 2 diabetes, used alongside a reduced-calorie diet and increased physical activity. Anyone considering it while on a specialist medicine should treat it as an addition that needs to be fitted around their existing care, not a swap.

Another practical point is timing. Because Mounjaro is injected once weekly, it stays in the system continuously rather than peaking and fading each day. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system¹. That matters if you and your specialist decide to stop it, because its effects do not vanish overnight.

Finally, remember that dose matters. Treatment starts on the lowest strength and steps up after at least four weeks under prescriber review, so what your body is experiencing in the early weeks differs from what it experiences later. If you are on a specialist medicine, tell both teams whenever your Mounjaro dose changes, so everyone has the same picture of your regimen.

05 · Why no simple yes

Why the answer depends on you

The answer depends on your own health and treatment.

Methotrexate is used in different ways for different conditions, and people differ in their other health problems and other medicines. Whatever the general position, your own history may change the answer. A rheumatology, dermatology or other specialist team looks at the whole picture, including how well your condition is controlled and what monitoring you already have.

A prescribing decision also involves weighing benefit against risk. For some people the benefits of weight management are substantial and the specialist is happy to proceed with a sensible plan. For others the specialist may prefer to wait, adjust something first, or monitor more closely. That judgement is clinical, and it is made with you.

So what is the dependable route? Read the Mounjaro leaflet¹³ and product information¹, check the methotrexate leaflet too, and bring both to the clinician who manages your methotrexate. Ask directly: is there any reason I should not add a once-weekly GIP and GLP-1 injection to my current treatment, and is there anything you want monitored differently?

If you would like to see how others have framed the question, our related guides on taking Mounjaro while on methotrexate and being on methotrexate before starting approach the same issue from different starting points.

One more caution. Do not treat a forum thread as evidence. Individual stories cannot tell you what will happen to you, and they are not a substitute for the product information or your clinician.

06 · What to tell prescribers

What to tell your prescribers before you combine them

The most protective thing you can do is prepare. A short, accurate medicines list lets every clinician make a better decision, and it takes only a few minutes to write.

Start with everything you take regularly: prescription tablets, injections, creams, inhalers and patches. Include methotrexate with its strength and how you take it, exactly as your clinic directs. Add anything you buy without a prescription, such as pain relief, vitamins and herbal or weight-loss supplements. Supplements marketed for weight loss are low-cost, carry no clinical oversight and their dosing is not standardised, so your prescriber needs to know about them.

Next, list your conditions. Mounjaro is supplied only after an online consultation reviewed by a GPhC-registered prescriber¹, and the questionnaire asks about your health history so that the prescriber can judge suitability. Answer it fully and truthfully. Leaving out a long-term condition or a specialist medicine to make approval easier would defeat the purpose of the check.

Then think about who needs to know what:

• The clinician who manages your methotrexate should know you are considering or starting Mounjaro, and your dose as it changes.
• Our prescribing team should know about methotrexate, any other specialist medicine, and any recent changes.
• Your GP should be kept informed so your records are consistent.
• Your pharmacist can answer questions about the leaflet in plain language.

Take questions with you. Useful ones include whether anything about your methotrexate regimen should change when you start, whether you need any extra check-ups, which symptoms should prompt a call, and what to do if you are ill and cannot keep medicines down.

Also tell clinicians about timing. If you take methotrexate by mouth, ask whether the schedule needs any thought around your weekly injection day. Do not guess. Your specialist knows how your regimen is built and can tell you what, if anything, to do differently.

Finally, keep your list current. Each time any dose changes, update it. When you reorder with us, suitability is re-checked rather than shipped automatically, so a new development in your health can be caught at that point. If you are ready to begin, the Mounjaro consultation is where that list goes.

07 · Side effects and warning signs

Side effects, overlap and warning signs

When two medicines are taken together, it can be hard to tell which one is behind a new symptom. That is a good reason to keep a simple record and to speak up early rather than waiting to see.

Every medicine has its own list of possible side effects, and the full lists are in the patient information leaflets. For Mounjaro, the leaflet is the place to look¹³, and the same goes for your methotrexate leaflet. Common effects include nausea, diarrhoea, vomiting, constipation and abdominal discomfort, and they usually ease as your body adjusts.

A practical approach is to keep a short diary during the first weeks after starting Mounjaro and after every dose increase. Note the date of each injection, how you feel in the following days, how well you are eating and drinking, and anything unusual. That gives your clinicians something concrete to work with if you need to call.

Contact your prescriber or GP promptly if you develop a new symptom you cannot explain, if a symptom is getting worse, or if you are unable to eat or drink normally. If you have severe, persistent stomach pain, swelling of the face, lips or throat, difficulty breathing, or yellowing of the skin or eyes, get medical help straight away. Do not stop or change methotrexate on your own because you suspect Mounjaro, and do not change your Mounjaro dose without speaking to your prescriber. Your team can only unpick what is happening if they know exactly what you have been taking.

You can also report a suspected side effect yourself through the MHRA Yellow Card scheme¹⁹. Reports help regulators spot patterns across many people, and you can make one for any medicine.

On the symptom side, be wary of any website that tells you a particular symptom is definitely caused by one medicine or the other. A symptom that is not on the leaflet list is not a listed side effect, and even listed effects need individual assessment.

Our service includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, and side-effect support. Use them. If something changes, tell us at the next review or sooner, rather than waiting until you reorder. Support can be reached by email at support@everydaymeds.co.uk or on 0333 207 0413.

08 · Arthritis and eligibility

Rheumatoid arthritis, other conditions and who can take Mounjaro

Having a long-term inflammatory condition does not automatically rule Mounjaro out, but it does not automatically rule it in either. The medicine is licensed for weight management in adults and for type 2 diabetes¹, and your suitability depends on whether you meet the criteria and whether a prescriber judges it appropriate for you.

People ask who cannot take Mounjaro or why someone might be refused. In broad terms, a prescriber looks at your weight and height in relation to the licence, your other health conditions, your current medicines and anything that might make treatment unsuitable. Specialist medicines are exactly the sort of detail that is weighed up. You should not take Mounjaro if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy; stop it at least one month before trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems.

It also helps to know what the NHS says. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you have a condition like rheumatoid arthritis, your NHS pathway matters too. Specialist teams often have views on weight and joint health, so ask whether weight management is something they would like to coordinate. That conversation might lead to NHS support, or it might confirm that a private route makes sense for you.

Do not assume that being on a specialist medicine counts against you. The prescriber is not looking for a reason to say no. They are looking for a safe way to say yes, or an honest reason to say not yet. Clear information from you makes the first outcome more likely whenever it is appropriate.

Treatment is used alongside a reduced-calorie diet and increased physical activity. If joint symptoms limit how active you can be, tell the prescriber and your specialist so the plan can be realistic. Supportive movement advice from your own clinical team is usually more useful than generic exercise guidance.

If you would like to see how our service frames this for people already on methotrexate, our page on private prescriptions alongside methotrexate explains the route.

09 · What to expect from treatment

What to expect from Mounjaro, and what can stall progress

If you and your clinicians decide to go ahead, it helps to hold realistic expectations. The headline evidence comes from the SURMOUNT-1 trial. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

Trial averages do not predict your own result. Someone managing a long-term condition may see a different pattern, and nobody can promise a particular outcome. What the figures show is that the medicine can be effective when used as licensed, with lifestyle support.

People often ask what stops others from losing weight on Mounjaro. Are you on the dose your plan intended, and have you had enough time at each step? Titration moves up after at least four weeks, and the early strengths are designed to build tolerance rather than to produce the largest effect. Are you eating in a way that supports a reduced-calorie diet? Are other medicines, or your underlying condition, affecting your appetite, energy or movement? These are conversations for your monthly review.

Do not try to speed things up by changing how you use the pen, stretching or adding doses, or combining it with unlicensed products. These are outside the licence and are not something we support. If progress feels slow, the right response is a review with your prescriber, not an experiment.

Equally, do not judge success on a single week. Appetite and fullness change gradually, and how you feel in the early weeks is not a reliable guide to the long-term picture. Keep a record of your dose, your weight trend and how you feel, so your reviews are based on evidence. Our free GLPTrackr companion app is designed for tracking a GLP-1 journey and is available on iOS and Android.

Remember also that Mounjaro is part of a plan. For someone on methotrexate, that plan includes the monitoring your specialist already provides. Keep every appointment you have, and tell each clinic about the others.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · Stopping, NHS or private

Stopping treatment, NHS versus private, and how ordering works

Sometimes a specialist will ask you to pause or stop one medicine, and it helps to know how that plays out. Mounjaro does not leave the body quickly. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system, there is no way to speed this up, and nothing needs doing while it clears.¹ If you are told to stop because of a possible clash, say so to everyone involved so they know the medicine will still be present for some time. Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, so stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

On access, the NHS route and the private route can sit side by side. Mounjaro is available on the NHS, but access is being phased in over several years, and NICE guidance sets who is recommended first.⁴ If you may qualify, speak to your GP or specialist about it. If you prefer not to wait, a regulated private consultation is an alternative. Check that any online provider is genuinely registered. Ours is a GPhC-registered pharmacy, registration 9012878, and you can verify it on the GPhC register¹².

Be careful about where you buy. Anybody offering to supply without a consultation or prescription is not operating safely, and counterfeit pens are a real concern. Our Mounjaro is supplied through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens.

If you decide to order, the process is simple:

• Complete the free online consultation, a short health questionnaire with no charge and no obligation. List methotrexate and every other medicine.
• A GPhC-registered prescriber reviews it, not a scoring script.
• Your order is dispensed by our registered pharmacy and sent with free next-day tracked delivery in discreet, temperature-controlled packaging. Same-day dispatch applies when ordered by 3pm.

Needles, a sharps bin and injection guidance come with every order. Ongoing monthly reviews are included, and repeat orders re-check suitability rather than auto-shipping, which suits anyone whose medicines may change. You can see the full details on the UK prescription page for people on methotrexate.

Mounjaro (tirzepatide) is a prescription-only medicine. This page is information, not a substitute for medical advice.